Samsara BioCapital, LLC - FORMA THERAPEUTICS HLDGS INC ownership

FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 141 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$21,255,000
+97.1%
1,065,413
-31.9%
4.96%
+72.4%
Q2 2022$10,786,000
-25.9%
1,565,5260.0%2.88%
-21.6%
Q1 2022$14,559,000
-34.6%
1,565,5260.0%3.66%
-15.1%
Q4 2021$22,262,000
-38.7%
1,565,5260.0%4.32%
-24.2%
Q3 2021$36,305,000
-6.8%
1,565,526
-0.0%
5.70%
+18.4%
Q2 2021$38,966,000
-11.2%
1,565,5290.0%4.81%
-40.5%
Q1 2021$43,866,000
-11.4%
1,565,529
+10.4%
8.09%
+62.5%
Q4 2020$49,507,000
-33.4%
1,418,529
-4.9%
4.98%
-76.0%
Q3 2020$74,369,000
+1.3%
1,492,163
-5.5%
20.74%
-12.1%
Q2 2020$73,379,0001,578,38823.60%
Other shareholders

There were no reported owners of FORMA THERAPEUTICS HLDGS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders